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Abstract
Introduction: Glucose control to prevent both hyperglycemia and hypoglycemia is important in an intensive care
unit. Arterial blood gas analyzers and glucose meters are commonly used to measure blood-glucose concentration
in an intensive care unit; however, their accuracies are still unclear.
Methods: We performed a systematic literature search (January 1, 2001, to August 31, 2012) to find clinical studies
comparing blood-glucose values measured with glucose meters and/or arterial blood gas analyzers with those
simultaneously measured with a central laboratory machine in critically ill adult patients.
Results: We reviewed 879 articles and found 21 studies in which the accuracy of blood-glucose monitoring by
arterial blood gas analyzers and/or glucometers by using central laboratory methods as references was assessed in
critically ill adult patients. Of those 21 studies, 11 studies in which International Organization for Standardization
criteria, error-grid method, or percentage of values within 20% of the error of a reference were used were selected
for evaluation. The accuracy of blood-glucose measurements by arterial blood gas analyzers and glucose meters by
using arterial blood was significantly higher than that of measurements with glucose meters by using capillary
blood (odds ratios for error: 0.04, P < 0.001; and 0.36, P < 0.001). The accuracy of blood-glucose measurements
with arterial blood gas analyzers tended to be higher than that of measurements with glucose meters by using
arterial blood (P = 0.20). In the hypoglycemic range (defined as < 81 mg/dl), the incidence of errors using these
devices was higher than that in the nonhypoglycemic range (odds ratios for error: arterial blood gas analyzers, 1.86,
P = 0.15; glucose meters with capillary blood, 1.84, P = 0.03; glucose meters with arterial blood, 2.33, P = 0.02).
Unstable hemodynamics (edema and use of a vasopressor) and use of insulin were associated with increased error
of blood glucose monitoring with glucose meters.
Conclusions: Our literature review showed that the accuracy of blood-glucose measurements with arterial blood
gas analyzers was significantly higher than that of measurements with glucose meters by using capillary blood and
tended to be higher than that of measurements with glucose meters by using arterial blood. These results should
be interpreted with caution because of the large variation of accuracy among devices. Because blood-glucose
monitoring was less accurate within or near the hypoglycemic range, especially in patients with unstable
hemodynamics or receiving insulin infusion, we should be aware that current blood glucose-monitoring
technology has not reached a high enough degree of accuracy and reliability to lead to appropriate glucose
control in critically ill patients.
* Correspondence: moriori@tg8.so-net.ne.jp; k_morita@cc.okayama-u.ac.jp
2Department of Anesthesiology and Resuscitology, Okayama University
Hospital, 2-5-1 Shikatachou, Okayama, Okayama 700-8525, Japan
Full list of author information is available at the end of the article
Inoue et al. Critical Care 2013, 17:R48
http://ccforum.com/content/17/2/R48
© 2013 Inoue et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Introduction
Glucose control to prevent both hyperglycemia and hypo-
glycemia is important in an intensive care unit [1]. Recent
meta-analysis, including results of the NICE-SUGAR
study [2], showed that intensive insulin therapy (target
blood-glucose control, 80 to 110 mg/dl) was not beneficial
and increased the risk of severe hypoglycemia in critically
ill patients [3-5]. Thus, it is currently recommended that
insulin should be used when the glucose concentration
exceeds 180 mg/dl, and target glucose concentration
should generally be between 144 and 180 mg/dl [6,7]
Even though a more-modest target for blood-glucose
concentration is now accepted, the importance of glucose
monitoring and its accuracy has become clearer. Because
the physiological activity of glucose is dependent on its
plasma concentration, central laboratory blood-glucose
measurement using plasma (Glu-lab) is recommended
[8,9]. However, arterial blood gas analyzers (ABGs) and/or
glucose meters, not Glu-lab, are commonly used to mea-
sure blood-glucose concentrations in critically ill patients,
because of their convenience and speed [10]. Because
most of these devices were not developed to guide the
administration of insulin in critically ill patients, they
might not be sufficiently accurate to guide therapy aimed
at maintaining blood glucose within a 30-mg/dl range
[11]. Therefore, knowledge of their limitations is essential
to minimize the possibility of a harmful measurement
error. However, no systematic literature review has
assessed the agreement of measurements by ABGs and/or
glucose meters in critically ill patients.
Accordingly, we performed a systematic review and
meta-analysis of selected observational studies on the
accuracy of blood-glucose measurements by using ABGs
(Glu-ABGs), glucose meters using capillary blood samples
(Gluco-C), and glucose meters using arterial blood sam-
ples (Gluco-A) in critically ill adult patients.
Materials and methods
Electronic database
We performed a systematic literature search (January 1,
2001, through August 31, 2012) to find clinical studies
comparing blood-glucose values measured by using ABGs
and/or glucose meters with those simultaneously mea-
sured with a central laboratory machine in critically ill
adult patients. The literature search was performed by
using MEDLINE and PubMed electronic databases with
the following key words: “intensive care”, “critical care,”
“glucose,” “sugar,” “glycemic,” “insulin,” “Bland Altman,”
“agreement,” “validation,” “reliability,” “accuracy,” “correla-
tion,” “Clarke grid,” and “bias.” All articles identified by
this search strategy were obtained, and their bibliographies
were studied for articles that might have been missed by
the electronic database search.
Inclusion and exclusion criteria
Inclusion criteria for the current systematic review
were as follows: (a) studies conducted in critically ill
adult patients, (b) studies in which the accuracy of glu-
cose monitoring was assessed by using ABGs and/or
glucose meters, (c) studies in which Glu-lab values
were used as reference values, and (d) articles present-
ing an appropriate summary of statistics. We excluded
nonhuman studies, non-English-language articles, and
pediatric studies.
Data extraction and interpretation
Two of the authors (SI and ME) extracted data from
selected articles, which were then reviewed by coauthors.
We paid particular attention to determine whether the
accuracy of blood-glucose monitoring was influenced by
types of devices and sites of blood collection. Because the
accuracy of blood-glucose monitoring in a hypoglycemic
range is important, we performed further assessment of
accuracy in a hypoglycemic range, defined as < 81 mg/dl.




Most of the studies were conducted by using (a) agree-
ment (percentages of blood-glucose values with an accep-
table error), and/or (b) bias (mean difference between
devices and reference) for evaluation.
Because the International Organization for Standardiza-
tion (ISO) criteria use agreement within ±20% of Glu-lab at
or above 75 mg/dl and within ±15 mg/dl below 75 mg/dl,
we defined primary outcome as percentages of blood-
glucose values within ±20% of the error of Glu-lab,
which involved Zone A of error-grid analysis (agreement
within ±20% of Glu-lab at or above 70 mg/dl) and agree-
ment with ISO criteria. We obtained rates of overestima-
tion and underestimation of blood-glucose measurements.
We defined proportion of nonagreement < 5% as good
quality of blood-glucose measurements according to ISO
criteria.
Secondary outcomes
We obtained the proportion of agreement by using cri-
teria other than the previously described criteria.
Because many reports showed the bias of each device,
we summarized their bias.
Statistical analysis
The current systematic review was performed by follow-
ing the MOOSE statement for observational studies [12].
Analysis was performed by using Review Manager (Rev-
Man) (The Cochrane Collaboration, 2008; The Nordic
Cochrane Centre, Copenhagen, Denmark). Heterogeneity
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was calculated by the I2 test, which shows the rate of
variation across studies due to heterogeneity rather than
to chance (ranging from 0 (no heterogeneity) to 100
(maximum heterogeneity)) [13]. Given the significant
heterogeneity found among the results of the studies, the
random-effects model was used [14]. All results are
reported with 95% confidence intervals. A P value < 0.05
was taken to indicate statistical significance.
Results
We identified 879 potentially relevant articles by the lit-
erature search. We excluded 716 studies because they
were animal studies, nonclinical studies, non-English-
language articles, or nonrelated studies. Of the remain-
ing 163 studies, 116 were excluded because they were
performed in infant or pediatric populations. Full text
reviews were conducted for the remaining 47 articles. In
21 of those 47 studies, the accuracy of blood-glucose
monitoring was assessed by using ABGs and/or gluc-
ometers with central laboratory methods as references
in critically ill adult patients (Figure 1).
Among the 21 selected studies [15-35], 11 studies
[15-25] used ISO criteria, the error-grid method, or per-
centage of values within 20% of the error of a reference;
three studies [26-28] used agreement with criteria other
than these criteria, and seven studies [29-35] used only
bias for evaluation (Figure 1, Table 1).
Bias of point of blood-glucose monitoring in adult
critically ill patients
Bias of point of blood-glucose monitoring in critically ill
adult patients was assessed in 20 studies (Table 2). Bias
was assessed for Glu-ABGs in five studies [15-18,20], for
Gluco-C in 13 studies [18,20-27,29-31,33,34], and for
Gluco-A in 12 studies [18,20-23,25,27,28,30-32,35]. The
mean differences varied between -2.7 mg/dl [17] and
=Electronic literature search= 
(sepsis OR septic OR intensive care OR critical care) AND  (glucose OR sugar OR glycemic OR insulin) 
AND  (Bland㻌 Altman OR agreement OR validation OR reliability OR accuracy OR correlation OR 
Clarke grid OR bias) (publish data 2000/01/01-2012/8/31) 
716 studies excluded  
(animal studies, non-clinical studies, non-English language papers, non-related studies) 
47 studies for full text review 
879 potentially relevant studies 
26 studies excluded (reference was not laboratory blood glucose method, non-critically ill) 
116 studies excluded (studies in Infant or pediatric patients) 
21 studies assessed the accuracy of blood glucose monitoring using ABGs and/or glucose meters using 
central laboratory methods as reference in adult critically ill patients. 
 
z 11 studies   using 1) International Organization for Standardization criteria, 2) error grid            
                                    analysis or 3) percentage of values within 20 %of reference value  
z   2 studies  using percentage of values within 10 %of reference value      
z   1 study  using percentage of values within 20 mg/dL difference from reference value      
z   7 studies using solely bias for evaluation 
Figure 1 Study selection for inclusion systematic review for accuracy of glycemic measurements in the critically ill patients.
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25.2 mg/dl [16] in Glu-ABGs, between -16 mg/dl [23]
and 9.9 mg/dl [22] in Gluco-C, and between -10 mg/dl
[23] and 23.0 mg/dl [32] in Gluco-A.
Limits of agreements were shown for Glu-ABGs in two
reports [15,17], for Gluco-C in 10 studies [21-24,26,29-31,
33,34], and for Gluco-A in seven studies [21-23,25,30-
32,35]. Its range (upper limit to lower limit) varied between
19 mg/dl [15] and 39 mg/dl [17] for Glu-ABGs, between
44 mg/dl [26] and 144 mg/dl [29] for Gluco-C, and
between 38 mg/dl [32] and 82 mg/dl [23] for Gluco-A.
Characteristics of 11 inclusion studies
Eleven studies [15-25] that used ISO criteria, error-grid
method, or percentage of values within 20% of the error of
Table 1 Observational studies to test the accuracy of point of blood-glucose monitoring in critically ill adult patients


















Pro 55 17 17 - Hexokinase method ○ - - 20% Yes [15]
Corstjens AM
(2006)
Pro (32-88) - 45 Every 6
hours
YSI2300 ○ - - 20% Yes [16]
Hoedemaekers CW
(2008)
Pro - - 32 1/pts Aeroset ○ - - 20% Yes [17]
Slater-MacLean L
(2008)
Pro 56 19 60 3 per day YSI2300 ○ ○ ○ 20% Yes [18]
Kanji S
(2005)
Pro 68 22 30 Every 5:00 LX-20 ○ ○ ○ 20% No [19]
Petersen JR
(2008)
Retro - - 84 1/pts Vitros950 or 5.1FS ○ ○ ○ 20% Yes [20]
Desachy A
(2008)
Pro 59 - 85 First 4
times
Dimension Vista device - ○ ○ 20% Yes [21]
Pulzi Júnior SA
(2009)
Retro 55 16 40 1/pts Au640e - ○ ○ 20% Yes [22]
Lonjaret L
(2012)
Pro 59 - 75 Every 5:00 Glucose oxidase method - ○ ○ 20% Yes [23]
Critchell CD
(2007)
Pro 59 16 80 Every 12 or
24 h
LX-20 - ○ - 20% Yes [24]
Meynaar IA
(2009)
Pro 72 18 32 Every 4 h Architect CI8200 - - ○ 20% Yes [25]
Cook A
(2009)
Pro 58 - 67 1/pts Au640 - ○ - 20 mg/dl Yes [26]
Karon BS
(2007)
Pro 69 - 20 First 5
hourly
Double P Modular system - ○ ○ 10% Yes [27]
Karon
(2008)
Pro - - - - Roche Integra 400 - - ○ 10% Yes [28]
Fekih Hassen M
(2010)
Pro 60 - 43 6/pts Dade-Behring Multichannel
Analyzer
- ○ - - Yes [29]
Finkielman JD
(2005)
Retro 56 - 197 - Glucose Analyzer 2 or
Hitachi 747-200
- ○ ○ - Yes [30]
Lacala T
(2007)
Pro 67 - 42 1/pts RxL - ○ ○ - Yes [31]
Mann EA
(2008)
Pro - - - - Vitros Fusion - - ○ - Yes [32]
Shearer A
(2009)
Pro 64 - 63 1/pts Au640 - ○ - - Yes [33]
Ray JG
(2001)
Pro 67 - 10 - Cobas Integra Analyzer - - ○ - Yes [34]
Denfeld QE
(2011)
Pro 61 - 46 1/pts DXC 800 - - ○ - Yes [35]
Labo, laboratory; ABG, arterial blood gas analyzer; Gluco-C, glucose meters using capillary blood samples; Gluco-A, glucose meters using arterial blood samples; ○,
device evaluated, -, not evaluated; pts, patients; Pro, prospective study; Retro, retrospective study.
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a reference were selected for further assessment (Table 1).
All of the 11 studies were single-center observational stu-
dies. Nine of the 11 studies were prospective studies
[15-19,21,23-25], and the other two studies were
retrospective studies [20,22]. Totally, 580 patients were
included in the 11 studies.
Various types of central laboratory machines were used
in the studies. The two methods for blood-glucose
Table 2 Bias of point of blood-glucose monitoring in critically ill adult patients
























ABL715 - - Mean D = 25.2 - - [16]
Hoedemaekers CW
(2008)









Mean D = 0.4 Mean D = 9.2
Mean D = -4.5
Mean D = 5.8
Mean D = 3.4
Mean D = -10.1




RapidLab860 Accu-Chek Inform Accu-Chek Inform - - - [19]
Petersen JR
(2008)
Rapidpoint405 Accu-Chek Inform Accu-Chek Inform Mean D = 1.8 Mean D = 9 Mean D = 12.6 [20]
Desachy A
(2008)
- Accu-Chek Sensor Accu-Chek Sensor - 1.5 (-55.3, 58.3) 1.4 (-39.5, 42.4) [21]
PulziJúnior SA
(2009)
- FreeStyle FreeStyle - 9.9 (-52.4, 72.1) 6.8 (-30.6. 44.1) [22]
Lonjaret L
(2012)
- Contour Contour - -16 (-59.1, 27.1) -10 (-51.2, 31.2) [23]
Critchell CD
(2007)
- Accu-Chek Inform - - 8.6 (-28.6, 45.8) - [24]
Meynaar IA
(2009)
- - Accu-Chek Inform - - 11 (-20.2, 42.2) [25]
Cook A
(2009)
- SuperStepFlexx - - 9.5 (-12.5, 31.5) - [26]
Karon BS
(2007)


















- Accu-Chek - - -0.9 (-74.3, 72.5) - [29]
Finkielman JD
(2005)
- SureStepFlexx SureStepFlexx - 7.9 (-27.2, 43.1)a 7.9 (-27.2, 43.1)a [30]
Lacala T
(2007)
- Sure Step pro Sure Step Pro - 1.0 (-23.1, 25.1) -0.1 (-21.7, 21.5) [31]
Mann EA
(2008)











- SureStepFlexx - - 8.7 (-18.2, 35.6) - [33]
Ray JG
(2001)
- - One-touch profile - - 0.7 (-39.6, 41.4) [34]
Denfeld QE
(2011)
- - Precision Xceedpro - - 12.3 (-6.9, 31.5) [35]
Bias was described as mean difference (95% confidence interval). ABG, arterial blood gas analyzer; Gluco-C, glucose meters using capillary blood samples, Gluco-
A, glucose meters using arterial blood samples; Ref, reference; Mean D, mean difference; IQR, interquartile range. aAnalysis of merged data from glucometer using
capillary and arterial samples.
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monitoring are the hexokinase method (Aeroset, Dimen-
tion, and Vista device, Au640e and Architect CI 8200)
[15,17, 21,22,25] and the glucose oxidase method (YSI
2300, Lx-20, Vitros950, and 5.1FS) [16,18-20,23,24]. All
machines had traceability to a higher-order reference
method.
Accuracy of blood-glucose measurements in the whole
glycemic range
Arterial blood glucose analyzers
The accuracy of Glu-ABGs including Cobas B 221 [15],
ABL 800 [15], Grem Premiere 3000 [15], ABL715 [16],
RapidLab [17], Chiron865 [18], Rapidlab 860 [19], and
Rapidpoint 405 [20] was assessed in six studies (Table 3).
Arterial blood samples were used in all of those studies.
The accuracy of Glu-ABGs was assessed by using ISO
criteria in one study [17], error-grid analysis in four stu-
dies [15,16,18,20], and 20% error in one study [19].
There were 1,444 assessments in the six studies. The
proportion of nonagreement varied from 0 to 42.8%. Five
(83.3%) studies showed good quality of blood-glucose mon-
itoring (nonagreement, < 5%). The proportion of nonagree-
ment was 12.5% in total. Overestimation of blood-glucose
concentrations was seen in 12.3% of all assessments.
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Glucose meters using capillary blood samples
In seven studies, the accuracy of Gluco-C, including
SuperStrepFlexx [18], AccuCheck Inform [18-20,24], Free-
Style [18,22], Accu-Chek Sensor [21], and Contour [23],
was assessed (Table 3). The accuracy of Gluco-C was
assessed by using ISO criteria in one study [24], error-grid
analysis in two studies [18,20], and 20% error in four
studies [19,21-23].
In the 2,778 assessments in the seven studies, the pro-
portion of nonagreement varied from 1.4% to 27.1%. One
study (14.3%) showed a good quality of blood-glucose
monitoring [18]. The proportion of nonagreement was
9.3%. Overestimation of blood-glucose concentrations was
seen in 4.8% of all assessments.
Glucose meters using arterial blood samples
In seven studies, the accuracy of Gluco-A, including
SuperStrepFlexx [18], AccuCheck Inform [18-20,25],
FreeStyle [18,22], Accu-Chek Sensor [21], and Contour
[23] was assessed (Table 3). The accuracy of Gluco-A
was assessed by using error-grid analysis in two studies
[18,20] and 20% error in five studies [19,21-23,25].
In the seven studies, 3,086 assessments were done. The
proportion of nonagreement varied from 0 to 12.3%. One
study (14.3%) showed good quality of blood-glucose
monitoring [18]. The proportion of nonagreement was
3.3% (n = 101). Overestimation of blood-glucose values
was seen in 1.3% of all assessments.
Meta-analysis to compare the accuracy of devices
In three studies, the accuracy of ABGs and that of glucose
meters were compared simultaneously [18-20]. Glu-ABGs
were significantly more accurate than Gluco-C (odds ratio
for nonagreement, 0.04; P < 0.001) (Figure 2A). Glu-ABGs
tended to be more accurate, but not significantly more
accurate, than Gluco-A (odds ratio for nonagreement,
0.17; P = 0.20) (Figure 2B).
In six studies, the accuracy of Gluco-A and that of
Gluco-C [18-23] were compared. Gluco-A results were
significantly more accurate than those of Gluco-C (odds
ratio for nonagreement, 0.36; P < 0.001) (Figure 2C).
Accuracy of blood-glucose measurements in the
hypoglycemic range
The accuracy of point of blood-glucose monitoring in
the hypoglycemic range was assessed for Glu-ABGs in
two studies [16,19], for Gluco-C in three studies
[19,23,24], and for Gluco-A in three studies [19,23,25]
(Table 4). The total number of assessments was 157 (59
assessments for ABGs, 52 assessments for Gluco-C, and
46 assessments for Gluco-A).
For ABGs, 13 of the 59 blood-glucose measurements
were outside the agreement range (22.0%), and all of
them overestimated blood-glucose values (22.0%). One
study by Kanji et al. [19] showed a high level of accuracy
of ABGs in the hypoglycemic range (nonagreement, none
of 37) [19]. For Gluco-C, 26 of the 77 blood-glucose mea-
surements were outside the agreement range (33.8%).
Overestimation of blood-glucose values was seen in 15
measurements (19.5%). For Gluco-A, 14 of the 71 blood-
glucose measurements were outside the agreement range
(19.7%). Overestimation of blood-glucose values was seen
in eight (11.3%) measurements.
Blood-glucose measurements in the hypoglycemic
range were less accurate than were those in the nonhypo-
glycemic range among all three devices (odds ratio for
error, Glu-ABGs, 1.86, P = 0.15; Gluco-C, 1.84, P = 0.03;
Gluco-A, 2.33, P = 0.02).
Factors associated with error of blood-glucose
measurements
In six studies, risk factors for inaccuracy of glucose mea-
surements were determined (five for Gluco-C, five for
Gluco-A, and none for ABGs) [20-25] (Table 5). Patient’s
factors (sex, body mass index, severity of illness, and pre-
sence of sepsis and/or diabetes), except for age, were not
significantly related to inaccuracy. Young age was signifi-
cantly associated with increased risk of nonagreement for
Gluco-C in one study [23]. No laboratory data (albumin,
lactate, PaCO2, PaO2, pH, and hematocrit) were associated
with inaccuracy.




















































ABG, arterial blood gas analyzer; Gluco-C, glucose meters using capillary blood samples; Gluco-A, glucose meters using arterial blood samples; Ref, reference.
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Slater-MacLean L (2008) 
Kanji S (2005) 
Petersen JR (2008) 
       ABG 
Glucometer 
(Capillary) 
Slater-MacLean L (2008) 
Kanji S (2005) 
Petersen JR (2008) 
       ABG 
Glucometer 
(Artery) 
 Slater-MacLean L (2008) 
 Kanji S (2005) 
 Petersen JR (2008) 
 Desachy A (2008) 
 PulziJúnior SA (2009) 










Favours ABG Favours Glucometer 
(Artery) 




Figure 2 The comparisons of accuracy of point of blood glucose monitoring. Size of data markers is proportional to the weight of each
study in the forest plot. ABG, arterial blood gas analyzers; CI, confidence interval.
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For Gluco-C, low perfusion index [36], use of a vaso-
pressor [22,24] and presence of edema [20,24] were signifi-
cantly associated with inaccuracy. For Gluco-A, use of a
vasopressor [23], low peripheral perfusion, and low mean
arterial pressure [21] were associated with inaccuracy.
Studies in which agreement of criteria other than “within
20%” was assessed
Our literature review retrieved three studies in which
agreement of criteria other than “within 20%” was assessed:
one study used within 20 mg/dl from the reference [26],
and two studies used within 10% of reference methods for
evaluation [27,28] (Table 6). No study showed a good qual-
ity of blood-glucose monitoring. One study (n = 20)
showed that blood-glucose measurements by Accu-Chek
Inform using arterial blood samples were less accurate
than those using capillary blood samples (odds ratio for
incidence of nonagreement, 2.21; P = 0.02) [27]. Another
study showed that accuracy of measurements with glucose
meters by using arterial blood samples were significantly
varied among devices (incidence of nonagreement (Stat-
Strip = reference): Accu-Chek Inform: odds ratio, 5.2;
P < 0.001, Precision PCx: odds ratio, 15.2; P < 0.001; SureS-
tepFlexx, odds ratio, 4.3; P < 0.001) [28].
Discussion
Although several reviews focused on the accuracy of point
of blood-glucose monitoring in critically ill patients
[10,37,38], our review is the first systematic review for this
issue. Our review shows comparisons among devices and
between hypo- and non-hypoglycemic ranges, as well as
problems in studies including variation of references and
insufficient data for a hypoglycemic range.
Although available data are often heterogeneous and
insufficient for meta-analysis, we found that the accuracy
of blood-glucose monitoring might vary, especially accord-
ing to the device, site of blood sampling, and glucose
range. With our systematic analysis of the 11 retrieved
articles, we considered that, despite the limitation of data,
some statements can be made to help establish current
knowledge of the accuracy of point of blood-glucose mon-
itoring in critically ill adult patients.
Statement 1: Type of central laboratory machine
(reference) is highly variable
The type of central laboratory machine varied among the
studies. Although all central machines used in the 11 stu-
dies have traceability of blood-glucose monitoring, it is
unclear whether these machines are equally accurate.
Thus, it is difficult to interpret whether the type of labora-
tory machine influenced the accuracy of point of blood-
glucose monitoring. If the central laboratory machine does
not have metrologic traceability for blood-glucose moni-
toring, it should be the case for quality-insurance pro-
grams requirements.
Statement 2: In few studies was the accuracy of ABGs
compared with that of a glucose meter simultaneously
In the variation of reference as in statement 1, the study
to compare the accuracy among Glu-ABGs, Gluco-C,









































































































































Definition, Definition of hypoglycemia; No of samples, Number of samples in hypoglycemic range; non-hypo, non-hypoglycemic. ABG, arterial blood gas analyzer;
Gluco-C, glucose meters using capillary blood samples; Gluco-A, glucose meters using arterial blood samples; CI, confidence interval; Ref, reference.
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Table 5 Risk factors for inaccuracy of glucose monitoring
First author (year) Sex Age BMI Severity
of
illness



















- - - - - - - - - - - - - - - - - - - + [20]
Desachy A
(2008)
- - - ○ - ○ - - - - - ○ - - + ○ - ○ ○ - [21]
PulziJúnior SA
(2009)
- - - - - - - - - - - - - - - - + ○ - - [22]
Critchell CD
(2007)
○ ○ - ○ ○ - ○ - ○ ○ ○ ○ - ○ - - + - - + [24]
Lonjaret L
(2012)




- - - - - - - - - - - - - - - - - - - ○ [20]
Desachy A
(2008)
- - - ○ - ○ - - - - - ○ - - ○ ○ - + + - [21]
PulziJúnior SA
(2009)
- - - - - - - - - - - - - - - - ○ ○ - - [22]
Meynaar IA
(2009)
- - - - - - - - - - - ○ - - - - - - - - [25]
Lonjaret L
(2012)
○ ○ ○ ○ - - - ○ - - ○ - + - - - + - - - [23]
BMI, Body mass index; DM, diabetes mellitus, Alb, serum albumin concentration; Lac, lactate concentration; Ht, hematocrit; P.I, perfusion index, MAP, mean arterial pressure, Ref, reference; Gluco-C, glucose meter;
using capillary blood samples; Gluco-A, glucose meters using arterial blood samples. +, factor significantly associated with disagreement of blood glucose monitoring. ○, factor not significantly associated with












and Gluco-A is essentially relevant. However, in only
three studies were the accuracies of these three com-
pared [18-20].
Statement 3: Accuracy of ABG analyzers might vary
among devices
The proportion of nonagreement in Glu-ABGs varied
widely (0 to 42.8%). Although five of the six studies
showed good quality of Glu-ABGs, and the range of lim-
its of agreements for Glu-ABGs (minimum of 19 mg/dl,
maximum of 39 mg/dl) was smaller than those for
Gluco-C and Gluco-A, one study showed overestimation
by Glu-ABGs in 42.8% of the samples. Although it is
unclear whether the type of central laboratory machine,
conditions of the measurement, or other unknown
mechanisms affected the results of that study, the results
suggested that accuracy of Glu-ABGs might vary among
devices. Thus, it is recommended that each institution
confirm the accuracy of their ABGs for blood-glucose
monitoring.
Statement 4: ABGs and a glucose meter using arterial
blood were significantly more accurate than a glucose
meter using capillary blood
Glu-ABGs and Gluco-A were significantly more accu-
rate than Gluco-C. Even when we included studies
using criteria other than within 20%, the finding did not
change (odds ratio for nonagreement, 0.43; P = 0.01).
Thus, for blood-glucose measurements in critically ill
adult patients, arterial blood samples should be used
rather than capillary blood samples.
Statement 5: Blood-glucose monitoring with ABG
analyzers tends to be more accurate than that with
glucose meters using arterial blood
Our meta-analysis showed that Glu-ABGs tend to be
more accurate than Gluco-A (P = 0.20). Additionally,
the range of limits of agreements in Glu-ABG was
smaller than that in Gluco-A. These results suggest that
Glu-ABGs might be more appropriate than Gluco-A.
However, it should be noted that the accuracy of
Gluco-A varied among studies, as stated earlier, and in
only three studies were they compared, and the results
were conflicting (odds ratios for error, 0.03 to 3.00).
Thus, further studies are needed to determine whether
Glu-ABGs, Gluco-A, or both can be recommended for
blood-glucose monitoring in a critically ill setting.
Statement 6: Information on the accuracy of blood-
glucose measurement in the hypoglycemia range is not
sufficient
Although more than 6,000 samples were assessed for the
accuracy of blood-glucose measurements (ABG, 1,360;
Glu-C, 2,858; Glu-A, 3,086), about 70 samples were in
the hypoglycemic range in each method (ABG, 58; Glu-
C, 77; Glu-A, 81). This number of samples is not suffi-
cient to compare between devices and determine the
risk factors of error. Therefore, further studies are
needed for blood-glucose measurements in the hypogly-
cemic range.
Statement 7: Blood-glucose monitoring in the
hypoglycemic range is less accurate than that in the
nonhypoglycemic range
Because many studies have shown that even mild hypo-
glycemia is significantly associated with increase in mor-
tality [39,40], accuracy of blood-glucose monitoring in
the hypoglycemic range is important. Although little
information is available for the hypoglycemic range, as
stated earlier, our results showed that the incidences of
errors in the hypoglycemic range were higher than those
in the nonhypoglycemic ranges.
Regardless of the method used for blood-glucose mon-
itoring, we should be aware that a greater possibility of
errors exists in the hypoglycemic range than in the non-
hypoglycemic range. We should confirm blood glucose
Table 6 Three studies in which agreement of criteria other than “within 20%” was assessed








SuperStepFexx Within 20 mg/dl No 10/64 (15.6%) [26]
Karon BS
(2007)
Accu-Chek inform Within 10% No 25/96 (26.0%) [27]
Gluco-A Karon BS
(2007)
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concentrations by using Glu-lab when we obtain blood-
glucose values within or near the hypoglycemic range.
Statement 8: Unstable hemodynamics and insulin infusion
might increase the risk of errors in blood-glucose
monitoring by using a glucose meter
Unstable hemodynamics (low perfusion index, use of a
vasopressor, presence of edema, and low mean arterial
pressure) and insulin infusion were associated with
increased risk of inaccuracy. These factors might decrease
peripheral blood-glucose concentrations through microcir-
culatory disturbance and increased tissue glucose con-
sumption [41,42]. Therefore, physicians should avoid using
either Gluco-A and Gluco-C in patients with unstable
hemodynamics and/or receiving insulin infusion.
Limitations
Our systematic review has some limitations. Our literature
search was performed by using only MEDLINE and
PubMed and was performed by only one author. The use
of other important databases, such as the Cochrane sys-
tematic reviews database, and selection by multiple
authors might have made the literature review more com-
prehensive. We also excluded non-English-language
reports, abstracts, and unpublished studies. Thus, some
findings may have been missed. However, the selection
was done with preset inclusion criteria and a careful
search of bibliographies so as to minimize selection bias.
Conclusions
Our literature review showed that ABGs were signifi-
cantly more accurate than glucose meters using capillary
blood and tended to be more accurate than glucose
meters using arterial blood. However, these results
should be interpreted with caution because of the large
variation of accuracy among devices. Because blood-glu-
cose monitoring was less accurate within or near the
hypoglycemic range, especially in patients with unstable
hemodynamics or receiving insulin infusion, we should
aware that current blood-glucose monitoring technology
has not reached a high enough degree of accuracy and
reliability to lead to appropriate glucose control in criti-
cally ill patients.
Key messages
• Accuracy of blood-glucose measurements using
arterial blood gas analyzers might vary among
devices.
• Blood-glucose monitoring with ABG analyzers
tends to be more accurate than that by glucose
meters with arterial blood.
• Arterial blood samples should be used rather than
capillary blood sample for blood-glucose measure-
ments in adult critically ill patients.
• In the hypoglycemic range, blood-glucose monitor-
ing is more inaccurate than that in the nonhypogly-
cemic range.
• Unstable hemodynamics and insulin infusion might
increase the risk of error in blood-glucose monitor-
ing with a glucose meter.
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